Short Summary
The dispute originated from a trade mark infringement suit where the plaintiff's case was dismissed for default. The plaintiff sought review, which the trial judge allowed. The defendant appealed this decision to the High Court. The court ultimately held that an appeal against a review order granted on grounds outside the scope of Order 47 is incompetent.
Detailed Summary
In trademark battles, the courtroom drama often centers on who copied whose mark—but sometimes the real fight is about procedure. A single procedural misstep can hand a litigant an undeserved victory, and the only way to undo it lies in understanding the strict limits of appellate review. This 1960 dispute between M. Agaiah and Mohd. Abdul Kereem is a masterclass in why procedural rules are not mere formalities—they are the gatekeepers of justice.
The dispute began as a trade mark infringement suit. At some point during the proceedings, the plaintiff's case was dismissed for default, meaning the plaintiff failed to appear or take the necessary steps to prosecute the claim. Rather than accepting this outcome, the plaintiff moved for a review of the dismissal order. The trial judge, exercising discretion, allowed the review—effectively reviving the plaintiff's case. Aggrieved by this revival, the defendant, Mohd. Abdul Kereem, appealed the review order to the High Court, seeking to overturn the trial judge's decision and restore the original dismissal.
The defendant's core argument was procedural: the trial judge had no business granting review in the first place. The plaintiff, on the other hand, presumably argued that the review was justified because of some error or sufficient cause. The legal friction centered on Order 47 of the Civil Procedure Code, which governs reviews of decrees and orders. The defendant contended that whatever grounds the trial judge relied upon fell outside the narrow scope permitted under Order 47, Rule 4(2). The plaintiff likely countered that the trial judge had acted within his jurisdiction and that the appeal itself was the improper move.
The High Court sided with the defendant. The court held that an appeal against an order granting review is only competent—that is, legally permissible—if the grounds on which the review was granted fall within the specific provisos of Order 47, Rule 4(2). Where the review was allowed on grounds that strayed outside those tightly defined exceptions, the resulting review order cannot be attacked in appeal. In other words, the appellate court found the defendant's appeal itself to be incompetent because the review order, even if questionable, did not meet the threshold for appellate scrutiny under the law. The outcome was defendant-favorable, leaving the review order intact but clarifying the strict boundaries within which such orders can be challenged.
For founders and IP professionals, this case is a stark reminder that procedural compliance is not optional. If you find yourself on the losing end of a review order, you cannot simply appeal and hope for the best—you must first verify that the grounds for review fall squarely within the limited exceptions prescribed by law. General grievances about the trial judge's reasoning or perceived errors will not sustain an appeal. The lesson is clear: know your procedural remedies before you rely on them, and ensure that every step you take in litigation is anchored in the specific provisions that authorize it.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Andhra HC (Pre-Telangana). Understanding the court's reasoning in Mohd. Abdul Kereem vs M. Agaiah is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Pharmacyclics Llc & Anr.vsHetero Labs Limited & Ors. / Natco Pharma Limited / Bdr Pharmaceuticals International Pvt Ltd / Shilpa Medicare Limited & Anr. / Alkem Laboratories Ltd
This Delhi High Court judgment addresses a batch of six suits alleging infringement of Indian Patent 262968, which covers the drug Ibrutinib. The plaintiffs sought an injunction against defendants who were launching or had launched the generic version of the patented drug. While the court dismissed one related writ petition, it granted interim relief restraining all defendants from manufacturing and marketing Ibrutinib pending the final disposal of the suits. Furthermore, the court allowed defendants to exhaust their existing stock, provided they file an affidavit detailing the batch numbers and expiry dates.
M/S Shenzhen Jiayz Photo Industrial Ltd.vsFlipkart Internet Pvt Ltd & Ors.
The Delhi High Court granted an ad-interim injunction in favor of M/S Shenzhen Jiayz Photo Industrial Ltd. against Flipkart Internet Pvt Ltd and associated sellers. The plaintiff alleged that unauthorized third-party sellers were using the registered 'BOYA' trademark to sell counterfeit microphones on the platform, causing reputational damage and fraud. The court recognized a prima facie case and granted the injunction, compelling the e-commerce platform to take steps to remove listings of fake products.
Parle Products Pvt LtdvsThe Registrar of Trade Marks & Anr.
This Letters Patent Appeal was filed by Parle Products Pvt Ltd challenging the order dated 10.03.2026 of the Single Judge, which had dismissed the appellant's challenge to the Registrar of Trade Marks' order dated 29.04.2025 allowing respondent no.2's application for registration of the trademark '20-20' in Class 30. The appellant claimed to be the prior adopter and registered proprietor of the marks '20-20', 'TWENTY-20' and 'T20' and alleged deceptive similarity with respondent no.2's mark. The Division Bench dismissed the appeal, holding that the appellant was guilty of approbation and reprobation since it had obtained its own registrations by asserting its marks were distinct from respondent no.2's mark, and could not now claim deceptive similarity to challenge the latter's registration.
Yangtze Memory Technologie Co LtdvsUnion Of India & Anr.
The petitioner challenged the grant of its patent application, arguing that it was prevented from filing a necessary divisional application due to the timing of the grant. The petitioner claimed diligent efforts and intent to file the division before the grant. However, the court dismissed the petition, holding that the Petitioner attempted to file the divisional application after the grant date.
Immunas Pharma, Inc.vsAssistant Controller of Patents and Designs, Government of India
Immunas Pharma appealed the rejection of its Indian Patent Application (No.5542/CHENP/2010), which was rejected primarily on grounds that the claimed 6E4 antibody was an inherent feature and not patent-eligible under Section 3(c) as it was discovered in nature. The High Court set aside the rejection, holding that the specific method of production made the antibody patentable.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.